Skip to content

Clinical application of therapeutic plasma exchange in acute respiratory distress syndrome

Clinical application of therapeutic plasma exchange in acute respiratory distress syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060941
Enrollment
Unknown
Registered
2022-06-14
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute respiratory distress syndrome

Interventions

Treatment group:Plasmapheresis
Control group:None

Sponsors

The First People's Hospital of Chenzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) The diagnosis met the "2012 Diagnostic criteria for ARDS -- Berlin New Definition; (2) Age > 18; (3) Receiving ICU treatment; (4) Did not participate in other clinical studies; (5) One or more of the following symptoms: I Oxygenation index < 300 II after adequate fluid resuscitation, vasoactive agents are required to maintain MVP=65mmHg or lactic acid =2.0mmmol/l III. Multiple organ dysfunction.

Exclusion criteria

Exclusion criteria: (1) complicated with end-stage tumor, or complicated with end-stage of other chronic diseases, such as immune deficiency or significant immunosuppression; (2) Pulmonary embolism, interstitial pneumonia or other serious pulmonary diseases; (3) primary severe organ dysfunction; (4) Contraindications of plasma exchange (5) pregnant women; (6) Refusal to sign informed consent.

Design outcomes

Primary

MeasureTime frame
28-day mortality rate;

Secondary

MeasureTime frame
Serum inflammatory factor;Mechanical ventilation time;Length of ICU stay;SOFA score;Oxygenation index;

Countries

China

Contacts

Public ContactLi Tao
litao.7@163.com18390457150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026